KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Change in Acquisitions & Divestments (2016 - 2026)

Medtronic's Change in Acquisitions & Divestments history spans 13 years, with the latest figure at $2.0 billion for Q1 2026.

  • For Q1 2026, Change in Acquisitions & Divestments rose 5.58% year-over-year to $2.0 billion; the TTM value through Jan 2026 reached $8.2 billion, down 3.88%, while the annual FY2025 figure was $8.5 billion, 14.16% up from the prior year.
  • Change in Acquisitions & Divestments for Q1 2026 was $2.0 billion at Medtronic, up from $1.9 billion in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $2.6 billion in Q2 2022 and bottomed at $1.6 billion in Q4 2023.
  • The 5-year median for Change in Acquisitions & Divestments is $2.0 billion (2023), against an average of $2.0 billion.
  • The largest annual shift saw Change in Acquisitions & Divestments tumbled 44.21% in 2022 before it soared 37.34% in 2024.
  • A 5-year view of Change in Acquisitions & Divestments shows it stood at $1.7 billion in 2022, then decreased by 7.84% to $1.6 billion in 2023, then surged by 37.34% to $2.2 billion in 2024, then dropped by 10.68% to $1.9 billion in 2025, then grew by 3.9% to $2.0 billion in 2026.
  • Per Business Quant, the three most recent readings for MDT's Change in Acquisitions & Divestments are $2.0 billion (Q1 2026), $1.9 billion (Q4 2025), and $2.0 billion (Q3 2025).